期刊文献+

心力衰竭患者血浆脑钠素含量及其与左心功能关系研究 被引量:16

A study of the correlation between the serum brain natriuretic peptide levels and the left cardiac function in patients with heart failure
下载PDF
导出
摘要 目的探讨心力衰竭患者血浆脑纳素(BNP)水平与心力衰竭严重程度、左室功能等因素的关系。方法采用免疫放射分析法测定122例心力衰竭患者治疗前后和20例对照组血浆BNP浓度;用心脏彩色多普勒超声诊断仪测定并比较各组左室射血分数(LVEF)、左心室舒张末期内径(LVEDD)。结果心力衰竭患者BNP浓度显著高于对照组(P<0.01);BNP水平随着心功能NYHA分级程度的加重而显著增高,其与LVEF呈负相关(r=-0.34,P<0.001),而与LVEDD呈正相关(r=0.65,P<0.001),治疗后随心功能好转BNP浓度下降,LVEF和LVEDD明显改善(P<0.05)。结论心力衰竭患者血BNP水平随着心力衰竭严重程度的增加而升高,并能较好反映左室功能状态。 Objective To investigate the correlation between the serum brain natriuretic peptide(BNP) levels and the severity of heart failure (HF) as well as left ventricular function (LVF) in patients with heart failure.Methods 122 patients with HF before and after treatment and 20 control subjects were investigated by measuring the serum BNP levels, the left ventricular ejection fraction (LVEF) and left ventricular end-diastolic diameter (LVEDD). Results The serum BNP levels in patients with HF were markedly higher than those of control subjects ( P 〈 0.01 ), and the increase of BNP levels was closely correlated with the severity of NYHA functional class. The BNP levels were correlated negatively with the LVEF (γ = - 0.34, P 〈 0. 001 ) and positively with the LVEDD (γ = 0.65, P 〈 0.001 ). After treatment LVEF and LVEDD in patients with HF were obviously improved ( P 〈 0. 05), however, the serum BNP levels were significantly decreased with the improvement of cardiac function. Conclusion The increase of BNP levels is closely correlated with the severity of HF, further more, the BNP levels may reflect the LVF clearly.
出处 《疑难病杂志》 CAS 2005年第6期337-339,共3页 Chinese Journal of Difficult and Complicated Cases
关键词 心力衰竭 脑钠素 心功能 左室射血分数 左室舒张末期内径 Heart failure Brain natriuretic peptide Cardiac ftmction LVEF LVEDD
  • 相关文献

参考文献10

  • 1Kjaer A, Hesse B. Heart failure and neuroendocrine activation: diagnostic,prognostic and therapeutic perspectives.Clin Physiol,2001,21(6):661-672.
  • 2Wieczorek ST,Wu AH,Christonson R,et al.A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure:a multicenter evaluation.Am Heart J,2002,144(5):834-839.
  • 3Tsutamoto T,Wada A,Maeda K,et al.Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure.J Am Coll Cardiol,2001,37(5):1 228-1 233.
  • 4Anand IS,Fisher LD,Chiang YT,et al.Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial(Val-HeFT).Circulation,2003,107(9):1 278-1 283.
  • 5Lubien E,De Maria A,Krishnaswamy P,et al.Utility of natriureic peptide in detecting diastolic dysfunction:comparison with Doppler velocity recordings.Circulation,2002,105(5):595-601.
  • 6Wright SP,Doughty RN,Pearl A, et al.Plasma amino-terminal pro-BNP and accuracy of heart failure diagnosis in primary care:a randomized,controlled trial.J Am Coll Cardiol,2003,42(10):1 793-1 800.
  • 7孟春,姚荣国,郭战利.脑型钠利尿肽与心力衰竭的诊断与治疗[J].疑难病杂志,2004,3(4):250-252. 被引量:3
  • 8Dao Q,Krishnaswamy P,Kazanegra R,et al.Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting.J Am Coll Cardiol, 2001,37(2):379-385.
  • 9Dahlof B,Devereux RB,Kjeldsen SE,et al.Cardiovascular morbidity and mortality in the Lorsartan Intervention For Endpoint reduction in hypertention study (LIFE):a randomized trial against atenolol.Lancet,2002,359(9 311):995-1 003.
  • 10Fisher C,Berry C,Blue L, et al.N-terminal pro-BNP,but not the new putative cardiac hormone relation,predicts prognosis in patients with chronic heart failure.Heart,2003,89(8):879-881.

二级参考文献23

  • 1[1]Hystad ME, Geiran OR, Attramadal H, et al. Regional cardiac expression and concentration of natriuretic peptides in patients with severe chronic heart failure. Acta Physiol Scand, 2001,171(4)395-403.
  • 2[2]McCullough PA. B-type natriuretic peptides. A diagnostic breakthrough in heart failure. Minerva Cardioangiol,2003,51 (2): 121-129.
  • 3[3]Magga J, Vuolteenaho O, Tokola H, et al. B-type natriuretic peptide: a myocyte-specific marker for characterizing load-induced alterations in cardiac gene expression. Am Med, 1998,30(Suppll): 39-45.
  • 4[4]Tremblay J, Desjardins R, Hum D, et al. Biochemistry and physiology of the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem,2002,203(1-2): 31-47.
  • 5[5]Chen HH,Bumett JC. The natriuretic peptides in heart failure:diagnostic and therapeutic potentials. Proc Assoc Am Physicians, 1999,111 (5): 406-416.
  • 6[6]Maisel, Padma K, Radmila K, et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J,2001,5:367-374.
  • 7[7]Tateishi J, Masutani M, Ohyanagi M, et al. Transient increase in plasma brain (B-type) natriuretic peptide after percutaneous transluminal coronary angioplasty. Clin Cardiol,2000,23(10) :776-780.
  • 8[8]Yamaguchi H, Yoshida J, Yamamoto K, et al. Elevation of plasma brain natriuretic peptide is a hallmark of diastolic heart failure independent of ventricular hypertrophy. JACC, 2004,7: 43 ( 1 ): 55-60.
  • 9[9]Koglin J, Pehlivanli S, Schwaiblmair M, et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol,2001,38(7) :1934-1941.
  • 10[10]Lee SC, Stevens TL, Sandberg SM, et al. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure. J Card Fail,2002,8(3):149-154.

共引文献2

同被引文献86

引证文献16

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部